Swiss Biotech Report 2018: The Swiss biotech industry continues to soar due to “world class patents”
The success of the Swiss biotech industry continues. In 2017, the success of recent years could be consolidated and even somewhat surpassed, as the latest statistics in the Swiss Biotech Report show. The report features the most important drivers of innovation and summarises issues and facts about the development of the Swiss biotech industry. The Swiss Biotech Report is compiled annually by a committee of representatives from public institutions - including the IPI - and local companies. In this report, authors from the IPI give specific emphasis to the quality of the patents, with half of Swiss biotech patents qualifying as “world class patents” with particularly high value creation potential.
15.02.2019 | Partners and initiatives
Young researchers are ready for the world of intellectual property
Successful interregional collaboration in the field of patents and health
Info event on using strategic patent analyses on 11.4.2018 in Zurich
14.02.2018 | Event
Stakeholder Discussions on: Innovation, availability and affordability of medical products. Can we achieve it all?
27.09.2017 | Event
Séminaire IPI / LES: «développements récents en droit des marques», jeudi le 9 novembre 2017 au Novotel Genève